Stock listing

NASDAQ:BDSX Biodesix, Inc. Stock

Home listing (NASDAQ) of Biodesix, Inc.

Follow Biodesix, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BDSX

$7.56 USD -0.84 (-10.0%)

Close on Nov 20, 2026

Past year +16.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$7.50 – $8.45 USDNov 20, 2026
Volume
205,366 sharesNov 20, 2026
Market cap
$83.83M USDAt the close on Nov 20, 2026 · price × 11.09M shares outstanding
52-week range
$5.26 – $31.97 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3.08M USDMedian day 101,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Biodesix, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BDSX · Home$7.56 USD-0.84 (-10.0%)205,366$8.17$8.445$7.50$8.40Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BDSX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$7.56-0.84-10.0%$8.17$8.445$7.50205,366
$8.40-0.48-5.4%$8.75$9.04$8.36168,629
$8.88-0.12-1.3%$8.81$9.18$8.779134,884
$9.00-0.88-8.9%$9.86$9.86$8.885258,896
$9.88+0.09+0.9%$10.06$11.32$9.85386,123
$9.79-0.33-3.3%$10.17$10.85$9.70297,068
$10.12+0.10+1.0%$10.05$11.30$9.678560,410
$10.02-0.32-3.1%$10.20$10.60$9.39575,482
$10.34+1.81+21.2%$8.318$10.94$7.72907,423
$8.53-11.31-57.0%$12.42$13.04$7.961,586,800
$19.84-1.65-7.7%$21.30$21.30$19.07185,600
$21.49+0.44+2.1%$21.56$22.23$20.42148,000
$21.05-0.73-3.4%$21.80$22.89$20.7438,800
$21.78-1.475-6.3%$23.24$23.31$21.3775,600
$23.26-1.465-5.9%$25.06$25.06$22.7067,100
$24.72+1.86+8.1%$22.94$24.87$22.9470,100
$22.86+0.91+4.1%$21.87$22.98$21.27101,300
$21.95+0.69+3.2%$21.41$22.43$20.11141,700
$21.26+0.08+0.4%$21.54$22.36$21.0260,900
$21.18-2.76-11.5%$23.66$23.70$21.11139,600
$23.94+0.010.0%$23.76$24.99$23.38138,800
$23.93+0.06+0.3%$24.07$24.55$23.6654,200
$23.87+0.47+2.0%$23.50$24.92$23.5049,300
$23.40-0.26-1.1%$23.68$25.24$23.0455,400
$23.66-1.05-4.2%$24.79$24.79$22.6079,600
$24.71+0.72+3.0%$23.92$24.77$23.8435,200
$23.99-1.01-4.0%$24.92$25.08$23.6580,900
$25.00-0.70-2.7%$25.79$25.79$24.8053,300
$25.70-0.32-1.2%$26.02$26.62$25.1941,000
$26.02+0.39+1.5%$25.68$26.64$25.6346,700
$25.63-0.79-3.0%$26.24$26.51$25.1096,000
$26.42-1.54-5.5%$27.50$27.78$26.0757,600
$27.96-1.10-3.8%$29.30$29.99$27.52102,200
$29.06+1.34+4.8%$27.72$30.00$26.53181,200
$27.72+0.39+1.4%$27.55$28.72$26.97124,300
$27.33-2.50-8.4%$29.45$29.70$26.33178,900
$29.83+0.69+2.4%$29.15$30.13$28.14161,300
$29.14-1.28-4.2%$30.57$31.21$28.56142,600
$30.42+1.32+4.5%$29.00$31.97$28.50204,700
$29.10-0.30-1.0%$29.47$30.17$28.4898,300
$29.40+0.11+0.4%$29.22$31.35$28.81120,500
$29.29+1.14+4.0%$27.99$29.49$27.6569,000
$28.15-0.28-1.0%$28.37$29.07$27.7557,000
$28.43-0.77-2.6%$29.36$29.99$27.56122,400
$29.20+0.39+1.4%$28.52$29.96$28.39100,900
$28.81+0.25+0.9%$28.99$29.42$28.5260,800
$28.56+0.86+3.1%$27.77$29.00$27.55100,500
$27.70+0.30+1.1%$27.40$28.00$26.4269,400
$27.40+0.435+1.6%$26.80$27.70$25.7555,000
$26.97+0.925+3.6%$26.12$27.14$25.8246,400
$26.04-1.04-3.8%$26.83$27.37$25.6053,500
$27.08+0.45+1.7%$26.77$27.80$26.7033,400
$26.63+0.45+1.7%$25.97$27.90$25.8986,400
$26.18-0.295-1.1%$26.23$26.76$25.4258,800
$26.48-0.685-2.5%$27.29$27.29$25.9556,500
$27.16+2.09+8.3%$25.21$27.40$24.07141,200
$25.07-1.275-4.8%$25.83$26.53$25.0267,500
$26.35-0.485-1.8%$26.71$27.10$25.7658,000
$26.83-1.65-5.8%$28.29$28.62$26.65108,500
$28.48-2.12-6.9%$30.64$31.06$28.32162,300
$30.60+2.525+9.0%$28.34$31.31$28.00216,000
$28.08+2.685+10.6%$25.70$30.00$25.41198,000
$25.39-1.24-4.7%$26.25$26.83$23.95244,000
$26.63+2.60+10.8%$24.25$27.11$24.11272,600
$24.03-1.51-5.9%$25.20$26.00$23.76229,200

Splits

1 split · NASDAQ:BDSX · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
Ticker
NASDAQ:BDSX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Biodesix, Inc. news

Biodesix, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
22 in the last 12 months · 130 in all · newest Nov 9, 2026 · oldest 2020
Calls
24 calls with a replay · 24 with a transcript · latest Nov 5, 2026
Decks
6 decks · latest November 2026

Where Biodesix, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BDSX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BDSXBOATSUnited StatesUSD

Valuation

EV/sales 1.0× against a median of 2.6×: 4th lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$105.4M USD
P/E
Loss
EV/sales
1.0×
EV/EBITDA
Negative EBITDA
Price/book
9.7×
Gross margin
Not reported
Operating margin
−18.7%
Net margin
−25.7%
Debt to equity
5.8×
Beta vs S&P 500
1.56

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Biodesix, Inc. · NASDAQ:BDSXUS$83.83MUS$105.4Mn/a1.0×n/a9.7×−25.7%5.8×1.56
BICO Group AB Class B · OMXSTO:BICOUS$102.7MUS$90.50Mn/a0.6×2.1×0.8×−28.3%0.3×n/a
Devyser Diagnostics AB · OMXSTO:DVYSRUS$99.24MUS$94.86M39.9×3.8×17.5×2.6×10.0%0.1×n/a
Quanterix Corporation · NASDAQ:QTRXUS$93.06MUS$47.06Mn/a0.3×n/a0.4×−75.0%0.1×1.87
Exagen Inc. · NASDAQ:XGNUS$92.10MUS$86.82Mn/a1.2×n/a6.7×−25.1%1.7×2.52
Bonraybio Co. Ltd. · TWSE:6955US$81.85MUS$65.60M25.0×6.5×18.1×4.1×32.5%0.0×n/a
Nightingale Health Oyj Class B · OMXHEX:HEALTHUS$77.17MUS$36.79Mn/a6.1×n/a1.4×−335.7%0.0×n/a
Lucid Diagnostics Inc. · NASDAQ:LUCDUS$77.14MUS$77.63Mn/a14.3×n/a13.0×−892.8%3.1×1.36
Seer, Inc. · NASDAQ:SEERUS$75.91M−US$58.25Mn/a−4.1×n/a0.4×−450.9%0.1×1.03
Selvita SA · GPW:SLVUS$75.22MUS$113.4Mn/a1.4×9.1×1.0×−0.6%0.5×n/a
Sera Prognostics, Inc. · NASDAQ:SERAUS$69.65MUS$28.84Mn/a300×n/a1.3×n/a0.1×0.57
Median of the othersUS$79.51MUS$71.62M32.5×2.6×13.3×1.4×−28.3%0.1×1.36

Forecasts

7 strong buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
32.17 USD · Analysts' mean
EPS, year to Dec 2026
-2.90 · 7 analysts
Revenue, year to Dec 2026
104.7M · 7 analysts

Team and board

Officers

OfficerRole
Scott HuttonChief Executive Officer
Robin Harper CowieChief Financial Officer
Brianna PhillipsVice President, Quality and Regulatory Affairs
Jessica OlbrichtVice President, Human Resources
Niki GivensVice President, Clinical Research
Gary PestanoChief Scientific Officer
James R. JettCo-Chief Medical Officer
Steve SpringmeyerCo-Chief Medical Officer

Board

DirectorRole
John PatienceChairman of the Board
Hany MassaranyDirector
Jean M. FranchiDirector
Jon Faiz KayyemDirector
Lawrence T. KennedyDirector
Matthew W. StrobeckDirector

Events

Calls

CallWhenStatus
Biodesix (NASDAQ:BDSX) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2026 Earnings CallWed, Aug 05, 2026 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q1 2026 Earnings CallMon, May 04, 2026 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2025 Earnings CallThu, Feb 26, 2026 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q3 2025 Earnings CallMon, Nov 03, 2025 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q1 2025 Earnings CallTue, May 13, 2025 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2024 Earnings CallThu, Apr 03, 2025 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q3 2024 Earnings CallFri, Nov 01, 2024 · 8:30 AM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2024 Earnings CallWed, Aug 07, 2024 · 4:30 PM ETReplay
All 24 calls
CallWhenStatus
Biodesix (NASDAQ:BDSX) Q1 2024 Earnings CallWed, May 08, 2024 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2023 Earnings CallFri, Mar 01, 2024 · 8:30 AM ETReplay
Biodesix (NASDAQ:BDSX) Q3 2023 Earnings CallTue, Nov 07, 2023 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2022 Earnings CallMon, Mar 06, 2023 · 8:00 AM ETReplay
Biodesix (NASDAQ:BDSX) Q3 2022 Earnings CallThu, Nov 03, 2022 · 8:00 AM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2022 Earnings CallThu, Aug 04, 2022 · 8:00 AM ETReplay
Biodesix (NASDAQ:BDSX) Q1 2022 Earnings CallWed, May 11, 2022 · 8:00 AM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2021 Earnings CallMon, Mar 14, 2022 · 8:30 AM ETReplay
Biodesix (NASDAQ:BDSX) Q3 2021 Earnings CallMon, Nov 15, 2021 · 9:00 AM ETReplay
Biodesix (NASDAQ:BDSX) Q2 2021 Earnings CallTue, Aug 10, 2021 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q1 2021 Earnings CallTue, May 11, 2021 · 4:30 PM ETReplay
Biodesix (NASDAQ:BDSX) Q4 2020 Earnings CallTue, Mar 16, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close−57.0%
Q2 2026Aug 5, 2026 · After close−3.0%
Q1 2026May 4, 2026 · After close+32.6%
Q4 2025Feb 26, 2026+18.6%
Q3 2025Nov 3, 2025 · After close+19.9%
Q2 2025Aug 7, 2025 · After close−10.4%
Q1 2025May 13, 2025 · After close−38.7%
Q4 2024Feb 27, 2025 · Before open−2.2%
Q3 2024Nov 1, 2024 · Before open−23.5%
Q2 2024Aug 7, 2024 · After close+3.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close0.0%
Q4 2023Mar 1, 2024 · Before open+2.6%
Q3 2023Nov 7, 2023 · After close−10.1%
Q2 2023Aug 7, 2023 · After close+3.9%
Q1 2023May 11, 2023 · After close−12.3%
Q4 2022Mar 6, 2023 · Before open−10.0%
Q3 2022Nov 3, 2022 · Before open+2.8%
Q2 2022Aug 4, 2022 · Before open+4.7%
Q1 2022May 11, 2022 · Before open−15.4%
Q4 2021Feb 14, 2022 · Before open−0.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck29 slidesNovember 2026
Investor Presentation (August 2026)Investor deck34 slidesAugust 2026
Q2 2025 Earnings PresentationEarnings32 slidesAug 7, 2025
Investor Presentation (August 2024)Investor deck24 slidesAug 15, 2024
Investor Presentation (September 2021)Investor deck22 slidesSep 9, 2021
Investor Presentation (January 2021)Investor deck50 slidesJan 8, 2021

Open Decks

IPO

Priced at US$18.00 a share on Oct 27, 2020.

Price
US$18.00 a share
Shares offered
4,000,000 shares of common stock
Offering size
US$72 million
Underwriters' option
Up to 600,000 more shares
Underwriters
MORGAN STANLEY, WILLIAM BLAIR, CANACCORD GENUITY, BTIG · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceAug 12, 2020
Filed publiclyOct 2, 2020
Amended 4 timesNewest Oct 26, 2020
Shares registered with an exchangeOct 26, 2020
Declared effective by the SECOct 27, 2020
Final prospectus, with the priceOct 29, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Oct 29, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue88.5M71.3M49.1M38.2M54.5M45.6M24.6M20.4M
Cost of revenue16.7M15.6M13.0M14.2M30.5M22.0M6.07M4.41M
Gross profit71.8M55.8M36.1M24.1M24.0M23.6M18.5M16.0M
Research and development12.0M9.56M9.99M13.1M12.8M10.8M10.5M8.19M
Selling, general and administrative87.5M80.5M67.4M61.5M50.5M34.9M30.6M25.9M
Operating income-27.9M-34.5M-41.3M-50.6M-40.9M-22.9M-26.7M-23.5M
Depreciation and amortization5.67M5.77M3.33M3.60M3.18M2.90M2.79M1.74M
EBITDA-22.2M-28.7M-38.0M-47.0M-37.8M-20.0M-23.9M-21.7M
Interest expense7.72M8.26M9.54M8.07M4.51M7.60M3.01M2.92M
Income before tax-35.3M-42.9M-52.1M-65.4M-43.2M-31.4M-30.7M-26.2M
Income tax000000629.0K211.0K
Net income-35.3M-42.9M-52.1M-65.4M-43.2M-65.4M-30.7M-26.2M
Earnings per share, basic-4.67-6.64-0.64-1.55-1.58-6.48-126.97-19.72
Earnings per share, diluted-4.67-6.64-0.64-1.55-1.58-6.48-126.97

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents19.0M26.2M26.3M43.1M32.7M62.1M5.29M5.91M
Receivables9.04M8.60M7.68M5.07M3.66M15.3M5.29M1.89M
Inventory1.40M1.40M2.90M3.20M800.0K700.0K
Current assets32.5M39.5M39.7M53.3M43.6M86.1M12.7M9.91M
Property, plant and equipment24.8M27.8M27.9M5.85M4.18M3.18M2.12M1.39M
Goodwill15.0M15.0M15.0M15.0M15.0M15.0M15.0M10.8M
Total assets87.5M97.2M99.1M92.9M76.1M121.1M45.0M39.1M
Accounts payable3.08M2.19M2.93M1.69M1.66M8.96M1.72M886.0K
Current liabilities17.4M14.3M33.4M22.8M29.0M32.1M22.6M4.47M
Long-term debt47.4M36.4M35.2M25.0M9.99M15.9M23.8M23.1M
Total debt50.0M40.0M40.1M30.1M10.1M28.1M36.0M23.1M
Total liabilities89.9M76.4M94.5M72.3M56.4M79.9M76.2M237.1M
Shareholders' equity-2.46M20.9M4.58M20.6M19.7M41.2M-225.1M-198.0M
Shares outstanding8.25M7.27M96.2M77.6M30.8M26.6M254.9K1.33M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-23.3M-48.6M-22.9M-45.0M-28.2M-21.4M-21.7M-17.7M
Capital spending-259.0K-3.23M-22.9M-3.30M-2.24M-1.95M-1.31M-617.0K
Free cash flow-23.5M-51.9M-45.8M-48.3M-30.5M-23.3M-23.0M-18.3M
Cash from investing-403.0K-3.44M-23.1M-3.53M-2.55M-2.93M-1.87M-617.0K
Cash from financing16.4M52.0M29.1M58.9M1.26M81.1M23.0M19.0M
Dividends paid-643.0K-328.0K
Share buybacks497.0K625.0K643.0K355.0K328.0K
Change in cash-7.26M-39.0K-16.8M10.4M-29.5M56.8M-626.0K738.0K

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13D/A · Big-stake notice, amendedNov 12, 2026Big-stake noticeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
8-K · Current reportNov 5, 2026Management or board changeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 2, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJun 18, 2026Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJun 1, 2026Other filingsSEC
424B3 · ProspectusMay 29, 2026Offer documentSEC
CORRESP · Letter to the SECMay 27, 2026Other filingsSEC
UPLOAD · Letter from the SECMay 26, 2026Other filingsSEC
S-3 · Registration statementMay 21, 2026Offer documentSEC
8-K · Current reportMay 20, 2026Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 8, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 4, 2026Quarterly reportSEC
8-K · Current reportMay 4, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 28, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 9, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 9, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 9, 2026Meeting noticeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
4 · Change in ownershipFeb 11, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 6, 2026Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 27, 2026Big-stake noticeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJan 26, 2026Big-stake noticeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 23, 2026Big-stake noticeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJan 13, 2026Big-stake noticeSEC
8-K/A · Current report, amendedJan 12, 2026ResultsSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
10-Q · Quarterly reportNov 3, 2025Quarterly reportSEC
8-K · Current reportNov 3, 2025ResultsSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
8-K · Current reportOct 1, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 23, 2025Big-stake noticeSEC
4 · Change in ownershipSep 23, 2025Insider tradeSEC
4 · Change in ownershipSep 19, 2025Insider tradeSEC
8-K · Current reportSep 15, 2025Current reportSEC
8-K · Current reportSep 11, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 3, 2025Big-stake noticeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMay 30, 2025Offer documentSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
8-K · Current reportMay 21, 2025Meeting outcomeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 20, 2025Big-stake noticeSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
8-K · Current reportMay 13, 2025ResultsSEC
ARS · Annual report to shareholdersApr 28, 2025Annual reportSEC
DEF 14A · Proxy statementApr 28, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 17, 2025Meeting noticeSEC
8-K · Current reportApr 17, 2025Management or board changeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
8-K · Current reportMar 28, 2025Current reportSEC
10-K · Annual reportMar 3, 2025Annual reportSEC
8-K · Current reportMar 3, 2025ResultsSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
4 · Change in ownershipFeb 12, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 11, 2025Other filingsSEC
144 · Notice of proposed saleFeb 11, 2025Other filingsSEC
144 · Notice of proposed saleFeb 11, 2025Other filingsSEC
144 · Notice of proposed saleFeb 11, 2025Other filingsSEC
S-8 · Registration statement for employee plansFeb 7, 2025Offer documentSEC
8-K · Current reportJan 10, 2025ResultsSEC
4 · Change in ownershipNov 22, 2024Insider tradeSEC
4 · Change in ownershipNov 22, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveNov 13, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveNov 13, 2024Other filingsSEC
424B3 · ProspectusNov 12, 2024Offer documentSEC
424B5 · ProspectusNov 12, 2024Offer documentSEC
CORRESP · Letter to the SECNov 7, 2024Other filingsSEC
CORRESP · Letter to the SECNov 7, 2024Other filingsSEC
4 · Change in ownershipNov 6, 2024Insider tradeSEC
4 · Change in ownershipNov 6, 2024Insider tradeSEC
4 · Change in ownershipNov 6, 2024Insider tradeSEC
4 · Change in ownershipNov 6, 2024Insider tradeSEC
4 · Change in ownershipNov 6, 2024Insider tradeSEC
UPLOAD · Letter from the SECNov 6, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 6, 2024Other filingsSEC
S-3 · Registration statementNov 1, 2024Offer documentSEC
S-3 · Registration statementNov 1, 2024Offer documentSEC
10-Q · Quarterly reportNov 1, 2024Quarterly reportSEC
8-K · Current reportNov 1, 2024ResultsSEC
8-K · Current reportAug 14, 2024Current reportSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
424B5 · ProspectusAug 7, 2024Offer documentSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
4 · Change in ownershipJul 18, 2024Insider tradeSEC
SC 13G · Big-stake noticeJun 24, 2024Big-stake noticeSEC
424B3 · ProspectusJun 5, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 5, 2024Other filingsSEC
CORRESP · Letter to the SECMay 31, 2024Other filingsSEC
S-1/A · Registration statement, amendedMay 24, 2024Offer documentSEC
CORRESP · Letter to the SECMay 24, 2024Other filingsSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMay 23, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedMay 23, 2024Big-stake noticeSEC
8-K · Current reportMay 23, 2024Meeting outcomeSEC
UPLOAD · Letter from the SECMay 17, 2024Other filingsSEC
SC 13G · Big-stake noticeMay 13, 2024Big-stake noticeSEC
4 · Change in ownershipMay 10, 2024Insider tradeSEC
4 · Change in ownershipMay 10, 2024Insider tradeSEC
4 · Change in ownershipMay 10, 2024Insider tradeSEC
4 · Change in ownershipMay 10, 2024Insider tradeSEC
4 · Change in ownershipMay 10, 2024Insider tradeSEC
144 · Notice of proposed saleMay 9, 2024Other filingsSEC

This page holds 200 of 602 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Biodesix, Inc.’s releases · as of Oct 30, 2026

Common shares
11,088,511
Fully diluted
11,088,511

Fully diluted

LineSharesAs of
Common shares11,088,511Oct 30, 2026

Share count over time

CountShares
Oct 30, 202611,088,511

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
AIGH Capital Management LLC686K6.2%US$20.5M+7,693Nov 2, 2026
Soleus Capital Management, L.P.668K6.0%US$19.9M+81,877Nov 16, 2026
Telemark Asset Management, LLC540K4.9%US$16.1M+50,000Nov 10, 2026
Vanguard323K2.9%US$9.64M−2,108Nov 13, 2026
abrdn288K2.6%US$8.58M−101KNov 10, 2026
Essex Investment Management Co LLC235K2.1%US$7M−7,373Oct 19, 2026
Marshall Wace, LLP186K1.7%US$5.54M+69,492Nov 13, 2026
Stempoint Capital LP142K1.3%US$4.22M+71,548Nov 16, 2026
Walleye Capital LLC125K1.1%US$3.72M+50,356Nov 13, 2026
Millennium115K1.0%US$3.42M+100KNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Opaleye Management Inc.87,0000.78%US$2.6M−93,000Nov 16, 2026
Two Sigma81,8060.74%US$2.44M−5,018Nov 16, 2026
Legato Capital Management LLC72,6210.65%US$2.17M−8,760Nov 10, 2026
Geode Capital65,5550.59%US$1.96M−2,102Nov 6, 2026
Bank of America65,3870.59%US$1.95M+38,649Nov 16, 2026
Perkins Capital Management Inc61,3350.55%US$1.83M+16,717Nov 2, 2026
Qube Research & Technologies Ltd56,9020.51%US$1.7MNewNov 13, 2026
Sei Investments Co56,1370.51%US$1.67M+18,842Nov 10, 2026
Jane Street53,4110.48%US$1.59M−38,095Nov 12, 2026
BlackRock52,4180.47%US$1.56M+9,392Nov 13, 2026
Susquehanna52,3600.47%US$1.56MNewNov 16, 2026
Trexquant Investment LP50,7280.46%US$1.51M−7,244Nov 16, 2026
Polar Asset Management Partners Inc.50,1000.45%US$1.49MNewNov 16, 2026
Gsa Capital Partners LLP44,3070.40%US$1.32M−2,682Nov 16, 2026
Citadel34,2590.31%US$1.02MNewNov 16, 2026
Renaissance Technologies32,3480.29%US$965K+3,700Nov 12, 2026
State Street30,5020.28%US$910K+12,700Nov 12, 2026
Informed Momentum Co LLC29,9940.27%US$895KNewNov 16, 2026
Bridgeway Capital Management, LLC28,6610.26%US$855K+2,626Nov 16, 2026
Blair William & Co27,7980.25%US$829K−13,750Nov 10, 2026
Quadrature Capital Ltd27,5680.25%US$822K+2,802Nov 13, 2026
Squarepoint Ops LLC26,1160.24%US$779K+10,407Nov 9, 2026
Prudential Financial Inc23,7890.21%US$710KNewNov 16, 2026
XTX Topco Ltd19,4330.18%US$580KNewNov 16, 2026
Connor, Clark & Lunn Investment Management Ltd.17,5740.16%US$524KNewNov 10, 2026
Acadian Asset Management LLC15,9380.14%US$472KNewNov 9, 2026
Northern Trust13,8590.12%US$413KNo changeNov 16, 2026
Goldman Sachs13,1630.12%US$393KNewNov 16, 2026
Empowered Funds, LLC12,6260.11%US$377KNewNov 13, 2026
Thompson Davis & Co., Inc.11,7500.11%US$351K+400Nov 5, 2026
UBS11,5160.10%US$344K−18,392Nov 10, 2026
Schonfeld Strategic Advisors LLC10,2630.09%US$306KNewNov 16, 2026
Cannell & Spears LLC8,9210.08%US$266KNo changeNov 12, 2026
HighTower Advisors, LLC7,6460.07%US$228KNewNov 9, 2026
Nia Impact Advisors, LLC7,3840.07%US$220KNewNov 4, 2026
Allworth Financial LP4,9650.04%US$148KNo changeNov 17, 2026
Barclays4,2570.04%US$127K+3,944Nov 6, 2026
Morgan Stanley3,6810.03%US$110K+3,620Nov 13, 2026
Aster Capital Management (DIFC) Ltd2,1970.02%US$65,537NewNov 12, 2026
Citigroup Inc976<0.01%US$29,114+918Nov 4, 2026

This page holds 50 of 58 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund204K1.8%US$4.6MNo changeJun 30, 2026
Vanguard Extended Market Index Fund72,0310.65%US$1.62M+28,239Jun 30, 2026
1290 Essex Small Cap Growth Fund58,9500.53%US$1.25M+28,025Jul 31, 2026
Fidelity Extended Market Index Fund21,0690.19%US$344K−1,333May 31, 2026
iShares Micro-Cap ETF17,4040.16%US$392KNewJun 30, 2026
Ultra-Small Company Fund15,0000.14%US$338KNewJun 30, 2026
Ultra-Small Company Market Fund10,0000.09%US$226KNo changeJun 30, 2026
Fidelity Total Market Index Fund6,6640.06%US$109KNo changeMay 31, 2026
Fidelity Series Total Market Index Fund6,0040.05%US$97,985+529May 31, 2026
Fidelity Nasdaq Composite Index Fund5,4830.05%US$89,483+2,496May 31, 2026
All 16 holders
HolderSharesOf the companyValueChangeAs of
Vanguard Institutional Total Stock Market Index Fund4,5050.04%US$102KNo changeJun 30, 2026
Vanguard Balanced Index Fund3,5330.03%US$79,669+769Jun 30, 2026
1290 VT Micro Cap Portfolio1,1560.01%US$26,068NewJun 30, 2026
Victory Extended Market Index Fund537<0.01%US$11,384NewJul 31, 2026
Corgi Genomics & Precision Medicine ETF462<0.01%US$10,418First reportJun 30, 2026
Total Stock Market Index Trust191<0.01%US$4,307NewJun 30, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Schuler Jack W
10% owner, Other: Emeritus Director
Buy100,000USD 10.02US$1MNov 10, 2026
Schuler Jack W
10% owner, Other: Emeritus Director
Buy15,000USD 24.47US$367KAug 12, 2026
Schuler Jack W
10% owner, Other: Emeritus Director
Buy13,700USD 24.01US$329KAug 11, 2026
Schuler Jack W
10% owner, Other: Emeritus Director
Buy13,900USD 24.25US$337KAug 10, 2026

Big stakes

HolderStakeSharesDate
SCHULER JACK W22.30%2.48MNov 10, 2026
Orin Hirschman7.70%758KMar 31, 2026
Telemark Asset Management, LLC5.40%428KJan 22, 2026
Soleus Capital Master Fund, L.P.5.10%525KJun 17, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jack W Schuler
Other companies: Hansen Medical Inc (Director · Aug 8, 2013 – Jun 15, 2015 · Past); Accelerate Diagnostics Inc (Director · Jun 26, 2012 – Dec 3, 2024 · Past); Oncternal Therapeutics Inc (Director · Mar 1, 2012 – Mar 1, 2012 · Past); Icos Corp (Director · May 11, 2006 – Jan 29, 2007 · Past); Stericycle Inc (Director · May 3, 2006 – Apr 30, 2018 · Past); Medtronic plc. (Director · Jan 27, 2006 – Jun 27, 2013 · Past)
Director · Since at least Jun 22, 2020
Jean Franchi
Other companies: Disc Medicine, Inc. (Chief Financial Officer · Since at least Feb 7, 2024); Replimune Group, Inc. (Chief Financial Officer · Dec 9, 2019 – May 16, 2023 · Past); Merrimack Pharmaceuticals Inc (Chief Financial Officer · Feb 15, 2018 – Dec 11, 2018 · Past)
Director · Since at least Oct 27, 2020
Jon Faiz Kayyem
Other companies: Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); GenMark Diagnostics Inc (SVP, Research & Development · May 28, 2010 – Feb 2, 2018 · Past)
Director · Since at least Dec 6, 2021
Ryan Siurek
Other companies: EverCommerce Inc. (Chief Financial Officer · Since at least Jul 10, 2023); Vail Resorts, Inc. (SVP, Controller & CAO · Apr 18, 2016 – Sep 28, 2020 · Past); SPRINT Corp (Vice President and Controller · Nov 6, 2009 – Jul 24, 2013 · Past)
Chief Accounting Officer · Dec 31, 2020 – May 8, 2023 · Past
Hany Massarany
Other companies: Accelerate Diagnostics Inc (Director · May 20, 2021 – Jun 28, 2024 · Past); GenMark Diagnostics Inc (President and CEO, Director · Nov 2, 2017 – Jan 23, 2020 · Past)
Director · Since at least Jul 1, 2020
John Patience
Other companies: Accelerate Diagnostics Inc (Director · Jun 26, 2012 – Dec 3, 2024 · Past); Stericycle Inc (Director · May 3, 2006 – May 23, 2018 · Past)
Chairman of the Board · Since at least Jun 23, 2020
Matthew W. Strobeck
Other companies: QuidelOrtho Corporation (Director · Since at least May 27, 2022); Accelerate Diagnostics Inc (Director · Apr 1, 2019 – Jan 23, 2024 · Past)
Director · Since at least Jun 18, 2020
Charles M Watts
Other companies: Accelerate Diagnostics Inc (Director · Apr 1, 2019 – May 19, 2023 · Past)
Director · Oct 27, 2020 – Mar 31, 2025 · Past
Scott Hutton
Other companies: The Spectranetics Corp (General Manager, VI · Jan 23, 2017 – Aug 9, 2017 · Past)
Chief Executive Officer · Since at least Oct 27, 2020
Brianna PhillipsVice President, Quality and Regulatory Affairs · Since at least Sep 14, 2026
All 21 people
PersonSeat
Chris VazquezChief Accounting Officer · Since at least Jul 3, 2023
Gary PestanoChief Development Officer · Since at least Oct 27, 2020
James JettCo-Chief Medical Officer · Since at least Mar 20, 2026
Jessica OlbrichtVice President, Human Resources · Since at least Nov 5, 2026
Kieran O'KaneChief Commercial Officer · Since at least Oct 27, 2020
Lawrence T. KennedyDirector · Since at least Nov 5, 2026
Lawrence T Kennedy JrDirector · Since at least Jan 3, 2023
Niki GivensVice President, Clinical Research · Since at least Nov 5, 2026
Robert William Georgantas IIIChief Scientific Officer · Oct 27, 2020 – Nov 21, 2022 · Past
Robin Harper CowieCFO, Sec'y & Treasurer · Since at least Oct 27, 2020
Steve SpringmeyerCo-Chief Medical Officer · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Biodesix, Inc.